Regorafenib is a inhibitor that focuses on VEGFR, TIE2, and a few other kinases. It’s used to treat metastatic colorectal cancer, GIST, and HCC. You can get it in 40 mg film-coated tablet form, usually in a bottle with 84 tablets.
The dose is usually 160 mg taken once every day for 21 days in every 28-day cycle. So, patients take Regorafenib from day 1 to day 21 of every 28 days, that’s four tablets a day for three weeks out of the month.
